Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis

Dermatology. 2007;214(4):333-5. doi: 10.1159/000100885.

Abstract

Background: Mastocytosis is a disorder that can be subdivided into two forms: cutaneous and systemic. Patients with cutaneous mastocytosis only may suffer from cosmetic problems. Topical steroid application has been shown to be effective in cases of limited skin lesions.

Methods: A case-controlled pilot study was conducted during a 6-weeks treatment using diluted 25% fluticasone propionate 0.05% cream under wet-wrap occlusion in 5 adults and 6 children. Improvement was measured up to the 24th week after treatment using the SCORMA Index.

Results: The results of this pilot study showed a partial but clear cosmetic improvement in 9 of the 11 patients. The mean SCORMA Index decreased after treatment from 38 to 26.

Conclusion: 25% dilution of fluticasone propionate 0.05% cream under wet-wrap occlusion is an alternative treatment modality for alleviating the symptoms of cutaneous mastocytosis, but the improvement may be moderate and fall short of the patient's expectations.

MeSH terms

  • Administration, Topical
  • Adult
  • Androstadienes / administration & dosage*
  • Anti-Inflammatory Agents / administration & dosage*
  • Case-Control Studies
  • Child
  • Emollients
  • Fluticasone
  • Humans
  • Mastocytosis, Cutaneous / drug therapy*
  • Occlusive Dressings
  • Pilot Projects
  • Treatment Outcome

Substances

  • Androstadienes
  • Anti-Inflammatory Agents
  • Emollients
  • Fluticasone